Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. (02566) reported on 06 February 2026 that it repurchased 79,200 H shares on the Hong Kong Stock Exchange at a highest price of HKD 10 and a lowest price of HKD 9.88, for a total cost of approximately HKD 790,449.9768. These shares are held as treasury shares, raising the total count of treasury shares from 3,422,600 to 3,501,800.

The transaction lowers the number of issued shares excluding treasury shares from 105,674,185 to 105,594,985, while the overall share count stays at 109,096,785. The announcement also notes that the moratorium period on new share issuances or treasury share sales extends until 08 March 2026.